Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Primitive neuroectodermal tumor of the cervix uteri is a rare cancer of cervix uteri derived from neural crest cells, histologically composed of small, round neoplatic cells with variable degree of neural, glial and ependymal differentiation. Macroscopically, the tumor is often a large, soft, poorly circumscribed mass with infiltrative borders and necrotic areas. It presents with dysfunctional vaginal bleeding or discharge, lower abdominal pain and uterine enlargement.
Biomarker and diagnostic research for primitive neuroectodermal tumor of the cervix uteri has been reported in the published literature.
No clinical trials have been registered for primitive neuroectodermal tumor of the cervix uteri.
68 publications have been identified in PubMed for primitive neuroectodermal tumor of the cervix uteri. Research spans Basic Science / Preclinical (22%), Review / Meta-Analysis (21%), and Epidemiology / Natural History (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 15 | 22% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 3:08 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
14 |
21% |
Disease patterns and progression | 12 | 18% |
Clinical study results | 9 | 13% |
Testing and diagnosis research | 8 | 12% |
Patient case studies | 8 | 12% |
New treatment approaches | 2 | 3% |
Kuchalska K (2026). [PMID: 41481409](https://pubmed.ncbi.nlm.nih.gov/41481409/). *Pediatr Hematol Oncol*. [Epidemiology / Natural History]
Jauhiainen MK (2026). [PMID: 41874350](https://pubmed.ncbi.nlm.nih.gov/41874350/). *Neuropathology*. [Diagnostic / Biomarker]
Su M (2026). [PMID: 41484768](https://pubmed.ncbi.nlm.nih.gov/41484768/). *Neurochem Res*. [Basic Science / Preclinical]
Xue E (2026). [PMID: 41221671](https://pubmed.ncbi.nlm.nih.gov/41221671/). *Head Neck*. [Basic Science / Preclinical]
Bayraktar FGİ (2026). [PMID: 41190732](https://pubmed.ncbi.nlm.nih.gov/41190732/). *Laryngoscope*. [Review / Meta-Analysis]
Ma Y (2026). [PMID: 42010939](https://pubmed.ncbi.nlm.nih.gov/42010939/). *Oncologist*. [Diagnostic / Biomarker]
Chen SF (2026). [PMID: 41467362](https://pubmed.ncbi.nlm.nih.gov/41467362/). *Head Neck*. [Epidemiology / Natural History]
Nishida A (2026). [PMID: 42203325](https://pubmed.ncbi.nlm.nih.gov/42203325/). *Anticancer Res*. [Clinical Trial Publication]
Sekimizu M (2026). [PMID: 41449573](https://pubmed.ncbi.nlm.nih.gov/41449573/). *Jpn J Clin Oncol*. [Diagnostic / Biomarker]
Rammouni L DO (2026). [PMID: 41763664](https://pubmed.ncbi.nlm.nih.gov/41763664/). *BMJ Case Rep*. [Case Report / Case Series]